发明名称 CD8+ T cells specific for peptide WVDNKTFSV that are specifically cytotoxic for IgE-positive target cells and methods of production.
摘要 Cytotoxic T lymphocytes (CTLs) specific for antigenic peptides derived from IgE molecules can be generated in vitro by stimulating resting naïve CD8 T cells. The IgE specific CTLs lyse the target cells loaded with IgE peptides in vitro and inhibit antigen specific IgE responses in vivo. In addition, adoptive transfer of the IgE specific CTL to an asthmatic mouse model can inhibit the development of lung inflammation and airway hypersensitivity. IgE specific CTL provides a treatment for allergic asthma and other IgE-mediated allergic diseases. Antigenic peptides identified from non-tumor self-antigens induce specific cytotoxic T lymphocyte in vitro. The CTL indicyed by peptides identified from CD40L can kill activated CD4 T cells. In vitro generated CTL specific for CD40L inhibit CD4-dependent antibody responses of all isotypes in vivo. In contrast, CTL indiced by antigenic peptides derived from IgE specifically inhibit IgE responses, and adoptive transfer of CD40L-specific CTL in NOD mice at early stage delay the development of diabetes in NOD mice. In vitro generated CTL specific for non-tumor self-antigens expressed on activated CD4 T cells regulate immune response in vivo.
申请公布号 EP2330187(A2) 申请公布日期 2011.06.08
申请号 EP20100181114 申请日期 2002.05.13
申请人 ORTHO-MCNEIL PHARMACEUTICAL, INC. 发明人 CAI, ZELING;JACKSON, MICHAEL R.;PETERSON, PER A.;SHI, WEIXING;KONG, YAN;DEGRAW, JULI
分类号 C12N5/071;C12N15/09;A61K35/12;A61K39/00;A61P3/10;A61P11/02;A61P11/06;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P37/02;A61P37/08;C12N5/07;C12N5/0783 主分类号 C12N5/071
代理机构 代理人
主权项
地址